Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | No | No |
Is net profit margin increasing? | No | No |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
Envista Holdings Corporation |
Solventum Corporation |
DENTSPLY SIRONA Inc. |
Straumann Holding AG |
Bioventus Inc. |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
NVST | SOLV | XRAY | SAUH.F | BVS | ALGN | |||
Return On Equity | ||||||||
Latest Twelve Months | -31% | 7% | -35% | 24% | -21% | 11% | ||
Fiscal Year - 1 | -2% | 12% | -4% | 24% | -39% | 12% | ||
Fiscal Year - 2 | 6% | 11% | -22% | 26% | -27% | 10% | ||
Fiscal Year - 3 | 7% | 12% | 8% | 29% | -2% | 23% | ||
Fiscal Year - 4 | 1% | NA | -1% | 7% | 28% | 78% | ||
Fiscal Year - 5 | 4% | NA | 5% | 24% | -36% | 34% | ||
Average | -3% | 10% | -8% | 22% | -16% | 28% | ||
Median | 3% | 11% | -3% | 24% | -24% | 17% | ||
Benchmarks | Ticker | |||||||
Envista Holdings Corporation | NYSE:NVST | |||||||
Solventum Corporation | NYSE:SOLV | |||||||
DENTSPLY SIRONA Inc. | NasdaqGS:XRAY | |||||||
Straumann Holding AG | OTCPK:SAUH.F | |||||||
Bioventus Inc. | NasdaqGS:BVS |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | NVST | SOLV | XRAY | SAUH.F | BVS | ALGN | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 2,511 | 8,254 | 3,793 | 2,504 | 573 | 3,999 | ||
Fiscal Year | 2,511 | 8,254 | 3,793 | 2,504 | 573 | 3,999 | ||
Fiscal Year - 1 | 2,567 | 8,197 | 3,965 | 2,277 | 512 | 3,862 | ||
Fiscal Year - 2 | 2,569 | 8,130 | 3,922 | 2,321 | 512 | 3,735 | ||
Fiscal Year - 3 | 2,509 | 8,171 | 4,231 | 2,022 | 431 | 3,953 | ||
Fiscal Year - 4 | 1,929 | 7,281 | 3,339 | 1,426 | 321 | 2,472 | ||
Fiscal Year - 5 | 2,285 | NA | 4,022 | 1,596 | 340 | 2,407 | ||
Net Income | ||||||||
Latest Twelve Months | (1,119) | 479 | (910) | 458 | (34) | 421 | ||
Fiscal Year | (1,119) | 479 | (910) | 458 | (34) | 421 | ||
Fiscal Year - 1 | (100) | 1,346 | (132) | 448 | (97) | 445 | ||
Fiscal Year - 2 | 238 | 1,343 | (950) | 435 | (104) | 362 | ||
Fiscal Year - 3 | 264 | 1,460 | 411 | 396 | (5) | 772 | ||
Fiscal Year - 4 | 43 | 1,138 | (73) | 91 | 16 | 1,776 | ||
Fiscal Year - 5 | 184 | NA | 256 | 306 | 9 | 443 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 6,605 | 13,943 | 7,370 | 3,322 | 811 | 6,084 | ||
Latest Fiscal Quarter | 5,351 | 14,457 | 5,753 | 3,619 | 728 | 6,215 | ||
Fiscal Year | 5,351 | 14,457 | 5,753 | 3,619 | 728 | 6,215 | ||
Fiscal Year - 1 | 6,605 | 13,943 | 7,370 | 3,322 | 811 | 6,084 | ||
Fiscal Year - 2 | 6,587 | 13,594 | 7,643 | 3,373 | 1,373 | 5,948 | ||
Fiscal Year - 3 | 6,574 | 14,075 | 9,239 | 2,968 | 1,226 | 5,942 | ||
Fiscal Year - 4 | 6,876 | NA | 9,350 | 2,549 | 494 | 4,830 | ||
Fiscal Year - 5 | 6,158 | NA | 8,603 | 2,390 | 472 | 2,501 | ||
Fiscal Year - 6 | 5,842 | NA | 8,687 | 1,865 | 443 | 2,052 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 4,174 | 11,666 | 3,293 | 1,836 | 174 | 3,630 | ||
Latest Fiscal Quarter | 2,935 | 2,959 | 1,942 | 2,040 | 148 | 3,852 | ||
Fiscal Year | 2,935 | 2,959 | 1,942 | 2,040 | 148 | 3,852 | ||
Fiscal Year - 1 | 4,174 | 11,666 | 3,293 | 1,836 | 174 | 3,630 | ||
Fiscal Year - 2 | 4,207 | 11,742 | 3,811 | 1,852 | 325 | 3,601 | ||
Fiscal Year - 3 | 4,058 | 12,059 | 4,996 | 1,495 | 459 | 3,623 | ||
Fiscal Year - 4 | 3,721 | NA | 4,932 | 1,205 | 144 | 3,234 | ||
Fiscal Year - 5 | 3,540 | NA | 5,093 | 1,363 | (25) | 1,346 | ||
Fiscal Year - 6 | 4,823 | NA | 5,121 | 1,201 | (23) | 1,253 |